Description

Simple

Clinical

Overview

Pharmacology

Indication

Investigated for use/treatment in periodontal disease.

Pharmacodynamic

Information currently not available.

Mechanism of action

MD05 has two components: the recombinant growth factor, rhGDF-5, a naturally occurring human protein that acts by promoting the growth of bone and the inorganic carrier, beta-Tricalcium phosphate (beta-TCP). Beta-TCP is a synthetic calcium phosphate biomaterial, which acts as a scaffold and space ma... Read more

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with MD05
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)